Publications by authors named "Philip Waid"

Claim this Profile
C
Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth.
Michele C Smith, Mary M Mader, James A Cook, Philip Iversen, Rose Ajamie, Philip P Waid

Mol Cancer Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthranilamide inhibitors of factor Xa.
David Mendel, Angela L Marquart, Sajan Joseph, Philip Waid, Ying K Yee

Bioorg Med Chem Lett· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors.
Rima S Al-awar, James E Ray, Kyle A Hecker, Jianping Huang, Philip P Waid

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analogues.
John T Randolph, Philip Waid, Charles Nichols, Daryl Sauer, Fortuna Haviv

J Med Chem· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis